Form 4: Elisabeth Sandoval Reports Stock and Option Awards in PROCEPT BioRobotics Corp Filing

Elisabeth Sandoval, a director at PROCEPT BioRobotics Corp, reports the acquisition of restricted stock units and stock options.

Summary

• Elisabeth Sandoval, a director of PROCEPT BioRobotics Corp, filed a Form 4 on June 6, 2024, reporting transactions that occurred on June 4, 2024.
• Sandoval acquired 1,376 shares of common stock in the form of restricted stock units (RSUs) at a price of $0.
• These RSUs vest in full on the earlier of June 4, 2025, or the date of the next annual meeting following the grant date, contingent upon continued service.
• Sandoval also acquired a stock option to buy 2,526 shares of common stock at an exercise price of $67.29.
• This stock option vests in full on the earlier of June 4, 2025, or the date of the next annual meeting following the grant date, contingent upon continued service.
• Following these transactions, Sandoval directly owns 2,526 derivative securities and 11,023 shares of common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, and the sentiment is neutral as it simply reports transactions.

Positives

• The grant of RSUs and stock options to a director aligns their interests with those of the shareholders.
• The vesting schedule tied to continued service incentivizes the director to remain with the company.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• The grant of equity to a director can align their interests with those of shareholders, potentially leading to better company performance.

Key Dates